These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19789385)

  • 21. Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort.
    Borràs N; Garcia-Martínez I; Batlle J; Pérez-Rodríguez A; Parra R; Altisent C; López-Fernández MF; Costa Pinto J; Batlle-López F; Cid AR; Bonanad S; Cabrera N; Moret A; Mingot-Castellano ME; Navarro N; Pérez-Montes R; Marcellini S; Moreto A; Herrero S; Soto I; Fernández-Mosteirín N; Jiménez-Yuste V; Alonso N; de Andrés-Jacob A; Fontanes E; Campos R; Paloma MJ; Bermejo N; Berrueco R; Mateo J; Arribalzaga K; Marco P; Palomo Á; Castro Quismondo N; Iñigo B; Del Mar Nieto M; Vidal R; Martínez MP; Aguinaco R; Tenorio M; Ferreiro M; García-Frade J; Rodríguez-Huerta AM; Cuesta J; Rodríguez-González R; García-Candel F; Dobón M; Aguilar C; Corrales I; Vidal F
    Thromb Haemost; 2020 Mar; 120(3):437-448. PubMed ID: 32135566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetic analysis of porcine von Willebrand disease: tight linkage to the von Willebrand factor locus.
    Bahou WF; Bowie EJ; Fass DN; Ginsburg D
    Blood; 1988 Jul; 72(1):308-13. PubMed ID: 2898953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease.
    Keeney S; Cumming A; Hay C
    Thromb Haemost; 1999 Nov; 82(5):1446-50. PubMed ID: 10595636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr).
    Iannuzzi MC; Hidaka N; Boehnke M; Bruck ME; Hanna WT; Collins FS; Ginsburg D
    Am J Hum Genet; 1991 Apr; 48(4):757-63. PubMed ID: 1673047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease.
    Ahmad F; Kannan M; Biswas A; Saxena R
    Ann Hematol; 2009 May; 88(5):479-83. PubMed ID: 18923835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis.
    Nichols WC; Lyons SE; Harrison JS; Cody RL; Ginsburg D
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3857-61. PubMed ID: 1673793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C1584: effect on von Willebrand factor proteolysis and von Willebrand factor antigen levels.
    Davies JA; Collins PW; Hathaway LS; Bowen DJ
    Acta Haematol; 2009; 121(2-3):98-101. PubMed ID: 19506354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance: von Willebrand disease type IIC Miami.
    Ledford MR; Rabinowitz I; Sadler JE; Kent JW; Civantos F
    Blood; 1993 Jul; 82(1):169-75. PubMed ID: 8324222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease.
    Kroner PA; Friedman KD; Fahs SA; Scott JP; Montgomery RR
    J Biol Chem; 1991 Oct; 266(29):19146-9. PubMed ID: 1918030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.
    Flood VH; Christopherson PA; Gill JC; Friedman KD; Haberichter SL; Bellissimo DB; Udani RA; Dasgupta M; Hoffmann RG; Ragni MV; Shapiro AD; Lusher JM; Lentz SR; Abshire TC; Leissinger C; Hoots WK; Manco-Johnson MJ; Gruppo RA; Boggio LN; Montgomery KT; Goodeve AC; James PD; Lillicrap D; Peake IR; Montgomery RR
    Blood; 2016 May; 127(20):2481-8. PubMed ID: 26862110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD.
    Siguret V; Lavergne JM; Chérel G; Boyer-Neumann C; Ribba AS; Bahnak BR; Meyer D; Piétu G
    Hum Genet; 1994 Feb; 93(2):95-102. PubMed ID: 7906671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory Testing for von Willebrand Factor: Factor VIII Binding (for 2N VWD).
    Mohammed S; Favaloro EJ
    Methods Mol Biol; 2017; 1646():461-472. PubMed ID: 28804848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A common frameshift mutation in von Willebrand factor does not alter mRNA stability but interferes with normal propeptide processing.
    Mohlke KL; Nichols WC; Rehemtulla A; Kaufman RJ; Fagerström HM; Ritvanen KL; Kekomăki R; Ginsburg D
    Br J Haematol; 1996 Oct; 95(1):184-91. PubMed ID: 8857958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory Testing for von Willebrand Factor Antigen (VWF:Ag).
    Favaloro EJ; Mohammed S; Patzke J
    Methods Mol Biol; 2017; 1646():403-416. PubMed ID: 28804844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetic defect of type I von Willebrand disease "Vicenza" is linked to the von Willebrand factor gene.
    Randi AM; Sacchi E; Castaman GC; Rodeghiero F; Mannucci PM
    Thromb Haemost; 1993 Feb; 69(2):173-6. PubMed ID: 8456430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.
    Favaloro EJ; Mohammed S
    Thromb Res; 2016 May; 141():202-11. PubMed ID: 26743192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene.
    Verweij CL; Quadt R; Briët E; Dubbeldam K; van Ommen GB; Pannekoek H
    J Clin Invest; 1988 Apr; 81(4):1116-21. PubMed ID: 2895123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies.
    Qin F; Impeduglia T; Schaffer P; Dardik H
    J Vasc Surg; 2003 Feb; 37(2):433-9. PubMed ID: 12563218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH
    Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.